Head of Marketing - Value Added Generics
Lupin
Summary
The Senior Director, Head of Marketing – Value Added Generics will lead U.S. marketing strategy and commercialization for Lupin’s growing portfolio of differentiated pharmaceutical products, including 505(b)(2), value-added/specialty generics, and biosimilars.
Job description
This leader will build and execute portfolio and brand strategies from business case evaluation, go-to-market strategy, early commercialization through launch and lifecycle management. The role requires a combination of strategic growth, marketing, launch excellence, market insights, payer, customer/channel understanding and cross-functional leadership to establish Lupin as a leader in differentiated/value-added generics and specialty pharmaceutical products.
Key Responsibilities
- Lead U.S. marketing strategy for 505(b)(2), value-added generics and specialty, biosimilars and other differentiated products.
- Develop portfolio, brand and commercialization strategies based on unmet patient/customer needs, product differentiation, competition, payer/market access and channel dynamics.
- Lead pre-launch and launch planning including segmentation, prioritization, targeting, positioning, messaging, market development, customer engagement and launch readiness.
- Build differentiated value propositions for HCPs, pharmacists, patients/caregivers, payers, organized providers/institutions, health systems, GPOs and other relevant customers.
- Establish annual and long-term marketing plans, priorities, resource allocation and KPIs across the portfolio.
- Partner with R&D, Regulatory, Medical Affairs, Portfolio and Business Development to incorporate commercial insights into product development and lifecycle strategy.
- Partner with Market Access, Pricing, Contracting and Sales/Key Accounts to integrate payer, reimbursement, formulary, institutional and channel considerations into brand strategy.
- Lead market research, competitive intelligence, patient/customer journey analysis and performance analytics to identify opportunities and optimize commercial strategy.
- Partner with Finance and Commercial Analytics on forecasting, business cases, scenario planning and investment decisions.
- Provide commercial input into portfolio evaluations, business development opportunities and lifecycle-management strategies.
- Lead cross-functional launch teams spanning Marketing, Medical, Market Access, Sales, Regulatory, Supply Chain, Finance and Commercial Operations.
- Build scalable marketing capabilities, processes and launch playbooks as Lupin’s differentiated portfolio expands.
- Lead, coach and develop marketing talent and external agency partners while maintaining appropriate budget and compliance oversight.
Qualification and Experience
- Bachelor’s degree in Business, Marketing, Life Sciences or related discipline; MBA, PharmD or advanced degree preferred.
- 12+ years of progressive pharmaceutical/biotech commercial experience with significant U.S. marketing experience.
- Demonstrated success in pharmaceutical product commercialization, including pre-launch and new product launches.
- Experience in 505(b)(2), specialty pharma, value-added/complex generics, biosimilars or differentiated pharmaceutical products strongly preferred.
- Experience with retail, LTC, institutional, specialty pharmacy, hospital/GPO, clinics, mail-order, value-based or payer-driven channels preferred.
- Strong understanding of U.S. payer/market access, reimbursement, customer and channel dynamics.
- Strong strategic, analytical and financial acumen with experience in forecasting, market research and business planning.
- Proven ability to lead cross-functional teams and influence senior stakeholders in a matrix organization.
- Entrepreneurial mindset with demonstrated ability to build new capabilities and operate successfully in evolving business environments.
- Strong executive presence, communication, leadership and people-development skills.
Requirements
- Bachelor’s degree in Business, Marketing, Life Sciences or related discipline
- 12+ years of progressive pharmaceutical/biotech commercial experience with significant U.S. marketing experience
- Demonstrated success in pharmaceutical product commercialization, including pre-launch and new product launches
- Strong understanding of U.S. payer/market access, reimbursement, customer and channel dynamics
- Strong strategic, analytical and financial acumen with experience in forecasting, market research and business planning
- Proven ability to lead cross-functional teams and influence senior stakeholders in a matrix organization
- Entrepreneurial mindset with demonstrated ability to build new capabilities
- Strong executive presence, communication, leadership and people-development skills
Benefits
- Discretionary 25% performance bonus
Company overview
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with a significant presence in over 100 countries worldwide. Founded in 1968 by Desh Bandhu Gupta, the company has grown into one of India's top pharmaceutical manufacturers and a major global player in the generic drug market. Lupin specializes in a comprehensive range of pharmaceutical products including branded and generic formulations, complex generics, biotechnology products, active pharmaceutical ingredients (APIs), and advanced drug delivery systems. The company maintains a strong therapeutic focus across multiple areas including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health. With 15 state-of-the-art manufacturing facilities and 7 research centers globally, Lupin employs over 20,000 professionals dedicated to improving patient health outcomes. The company's U.S. subsidiary, Lupin Pharmaceuticals Inc., operates from Baltimore, Maryland, and has established itself as a significant player in the American pharmaceutical market. Lupin's commitment to innovation, quality, and accessibility has positioned it as a trusted provider of healthcare solutions that address unmet medical needs while maintaining a strong focus on sustainability and corporate social responsibility.